T-cell Prolymphocytic Leukemia: Update and Focus on Alemtuzumab (Campath-1H)

References

• Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (2000) "The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting—Airlie House, Virginia, November, 1997", Hematol. J. 1, 53–66.
   PubMedGoogle Scholar
• Thiel, E., Bauchinger, M., Rodt, H., Huhn, D., Theml, H. and Thierfelder, S. (1977) "Evidence for monoclonal proliferation in prolymphocytic leukemia of T-cell origin. A cytogenetic and quantitative immunoautoradiographic analysis", Blut 35, 427–436.
   PubMedGoogle Scholar
• Turchini, ME, Geneix, A., Travade, P., Delarocque, A., Chassagne, J., Mathe, O. and Malet, P. (1984) "Cytogenetic studies in a case of T-cell prolymphocytic leukemia", Cancer Genet. Cytogenet. 12, 171–174.
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle, V, Pomfret, M., Matutes, E. and Catovsky, D. (1987) "Cytogenetic studies on prolymphocytic leukemia II. T cell prolymphocytic leukemia", Blood 70, 926–931.
   PubMed Web of Science ®Google Scholar
• Heinonen, K., Mahlamaki, E., Hamalainen, E., Nousiainen, T. and Mononen, I. (1994) "Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia", Cancer Genet. Cytogenet. 78, 28–35.
   PubMed Web of Science ®Google Scholar
• Maljaei, S.H., Brito-Babapulle, V, Hiorns, L.R. and Catovsky, D. (1998) "Abnormalities of chromosomes 8, 11, 14 and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization", Cancer Genet. Cytogenet. 103, 110–116.
   PubMed Web of Science ®Google Scholar
• Virgilio, L., Isobe, M., Narducci, M.G., Carotenuto, P., Camerini, B., Kurosawa, N., Abbas ar, R., Croce, C.M. and Russo, G. (1993) "Chromosome walking on the TCL1 locus involved in T-cell neoplasia", Proc. Natl Acad. Sci. USA 90, 9275–9279.
   PubMed Web of Science ®Google Scholar
• Fu, T.B., Virgilio, L., Narducci, M.G., Facchiano, A., Russo, G. and Croce, C.M. (1994) "Characterization and localization of the TCL-1 oncogene product", Cancer Res. 54, 6297–6301.
   PubMed Web of Science ®Google Scholar
• Virgilio, L., Narducci, M.G., Isobe, M., Billips, L.G., Cooper, M.D., Croce, C.M. and Russo, G. (1994) "Identification of the TCL1 gene involved in T-cell malignancies", Proc. Natl Acad. Sci. USA 91, 12530–12534.
   PubMed Web of Science ®Google Scholar
• Roos, J., Hennig, I., Schwaller, J., Zbaren, J., Dummer, R., Burg, G., Tobler, A., Virgilio, L., Croce, C.M., Fey, MP. and Borisch, B. (2001) "Expression of TCL1 in hematologic disorders", Pat hobiology 69, 59–66.
   Google Scholar
• Virgilio, L., Lazzeri, C., Bichi, R., Nibu, K., Narducci, M.G., Russo, G., Rothstein, J.L. and Croce, C.M. (1998) "Deregulated expression of TCL1 causes T-cell leukemia in mice", Proc. Natl Acad. Sci. USA 95, 3885–3889.
   PubMed Web of Science ®Google Scholar
• Kunstle, G., Laine, J., Pierron, G., Kagami Si, S., Nakajima, H., Hoh, F., Roumestand, C., Stern, M.H. and Noguchi, M. (2002) "Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1", Mol. Cell. Biol. 22, 1513–1525.
   PubMed Web of Science ®Google Scholar
• Laine, J., Kunstle, G., Obata, T. and Noguchi, M. (2002) "Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family", J. Biol. Chem. 277, 3743–3751.
   PubMed Web of Science ®Google Scholar
• Pekarsky, Y., Koval, A., HaIlas, C., Bichi, R., Tresini, M., Malstrom, S., Russo, G., Tsichlis, P. and Croce, CM. (2000) "Tc11 enhances Akt kinase activity and mediates its nuclear translocation", Proc. Natl Acad. Sci. USA 97, 3028–3033.
   PubMed Web of Science ®Google Scholar
• Bartlett, N.L. and Longo, D.L. (1999) "T-small lymphocyte disorders", Semin. Hematol. 36, 164–170.
   PubMed Web of Science ®Google Scholar
• Matutes, E., Brito-Babapulle, V, Swansbury, J., Ellis, J., Morilla, R., Dearden, C., Sempere, A. and Catovsky, D. (1991) "Clinical and laboratory features of 78 cases of T-prolym-phocytic leukemia", Blood 78, 3269–3274.
   PubMed Web of Science ®Google Scholar
• Jennings, CD. and Foon, K.A. (1997) "Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy", Blood 90, 2863–2892.
   PubMed Web of Science ®Google Scholar
• Foa, R., Pelicci, P.G., Migone, N., Lauria, E, Pizzolo, G., Hug, F., Knowles, D.M. and Dalla-Favera, 2nd, R. (1986) "Analysis of T-cell receptor beta chain (T beta) gene rearrangements demonstrates the monoclonal nature of T-cell chronic lymphoproliferative disorders", Blood 67, 247–250.
   PubMed Web of Science ®Google Scholar
• Sugimoto, T., Imoto, S., Matsuo, Y., Kojima, K., Yasukawa, M., Murayama, T., Kohfuku, J., Mizuno, I., Yakushijin, K., Sada, A., Nishimura, R. and Koizumi, T. (2001) "T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype", Ann. Hematol. 80, 749–751.
   PubMed Web of Science ®Google Scholar
• Lamy, T. and Loughran, T.P. (1998) "Large granular lymphocyte leukemia", Cancer Control 5, 25–33.
   PubMedGoogle Scholar
• Glass, L.F., Keller, K.L., Messina, J.L., Dalton, J., Yag-Howard, C. and Fenske, NA. (1998) "Cutaneous T-cell lymphoma", Cancer Control 5, 11–18.
   PubMedGoogle Scholar
• Dahmoush, L., Hijazi, Y, Barnes, E., Stetler-Stevenson, M. and Abati, A. (2002) "Adult T-cell leukemia Ilymphoma: a cytopathologic, immunocytochemical, and flow cytometric study", Cancer 96, 110–116.
   PubMed Web of Science ®Google Scholar
• Garand, R., Goasguen, J., Brizard, A., Buisine, J., Charpentier, A., Claisse, J.F., Duchayne, E., Lagrange, M., Segonds, C., Troussard, X. and Flandrin, G. (1998) "Indolent course as a relatively frequent presentation in T-prolymphocytic leukae-mia. Groupe Francais d'Hematologie Cellulaire", Br. J. Haematol. 103, 488–494.
   PubMed Web of Science ®Google Scholar
• Domingo-Domenech, E., Gonzalez-Barca, E., Salar, A., Clams, A.D. and Granena, A. (1999) "Indolent course as presentation in t-prolymphocytic leukaemia", Br. J. Haematol. 105, 840.
   PubMed Web of Science ®Google Scholar
• Palomera, L., Domingo, J.M., Agullo, J.A. and Soledad Romero, M. (1995) "Complete remission in T-cell prolym-phocytic leukemia with 2-chlorodeoxyadenosine", J. Clin. Oncol. 13, 1284–1285.
   PubMed Web of Science ®Google Scholar
• Islam, A., Majer, R., Cumber, P. and Poynton, C. (1996) "Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia", Clin. Lab. Haematol. 18, 125–126.
   PubMedGoogle Scholar
• Mercieca, J., Matutes, E., Dearden, C., MacLennan, K. and Catovsky, D. (1994) "The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype", J. Clin. Oncol. 12, 2588–2593.
   PubMed Web of Science ®Google Scholar
• Ginaldi, L., De Martinis, M., Matutes, E., Farahat, N., Morilla, R., Dyer, M.J. and Catovsky, D. (1998) "Levels of expression of CD52 in normal and leukemic B and T-cells: correlation with in vivo therapeutic responses to Campath-1H", Leuk. Res. 22, 185–191.
   PubMed Web of Science ®Google Scholar
• Pawson, R., Dyer, M.J., Barge, R., Matutes, E., Thornton, P.D., Emmett, E., Kluin-Nelemans, J.C., Fibbe, WE., Willemze, R. and Catovsky, D. (1997) "Treatment of T-cell prolymphocytic leukemia with human CD52 antibody", J. Clin. Oncol. 15, 2667–2672.
   PubMed Web of Science ®Google Scholar
• Keating, M.J., Cazin, B., Coutre, S., Birhiray, R., Kovacsovics, T., Langer, W., Leber, B., Maughan, T., Rai, K., Tjonnfjord, G., Bekradda, M., Itzhaki, M. and Herait, P. (2002) "Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed", J. Clin. Oncol. 20, 205–213.
   PubMed Web of Science ®Google Scholar
• Cheson, B.D., Bennett, J.M., Greyer, M., Kay, N., Keating, M.J., O'Brien, S. and Rai, KR. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lympho-cytic leukemia: revised guidelines for diagnosis and treatment", Blood 87, 4990–4997.
   PubMed Web of Science ®Google Scholar
• Coutre, S., Rai, K., Keating, M., Gribben, J.G., Flinn, I., Rabinow, S. and Rizzierie, D. (2001) "Efficacy and safety of alemtuzumab (Campath-1H) used on a compassionate basis in refractory T-PLL (abstract)", Blood 98, 1542a.
   PubMed Web of Science ®Google Scholar
• Campath Prescribing Information. Berlex Laboratories, Inc. May 2001, Richmond, California.
   Google Scholar
• Nguyen, D.D., Cao, TM., Dugan, K., Starcher, S.A., Fechter, R.L. and Coutre, S.E. (2002) "Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leuke-mia", Clin. Lymphoma 3, 105–110.
   PubMedGoogle Scholar
• Collins, R.H., Pineiro, L.A., Agura, E.D. and Fay, J.W. (1998) "Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation", Bone Marrow Transplant. 21, 627–628.
   PubMed Web of Science ®Google Scholar
• Billio, A., Pescosta, N., Rosanelli, C., Fabris, P. and Coser, P. (2000) "A brief intensive chemotherapy in T-prolymphocytic leukemia", Haematologica 85, 438–439.
   PubMed Web of Science ®Google Scholar
• Garderet, L., Bittencourt, H., Kaliski, A., Daniel, M., Ribaud, P., Socie, G. and Gluckman, E. (2001) "Treatment of T-prolymphocytic leukemia with nonmyeloablative allo-geneic stem cell transplantation", Fur. J. Haematol. 66, 137–139.
   PubMed Web of Science ®Google Scholar
• Dearden, CE., Matutes, E., Cazin, B., Tjonnfjord, G.E., Parreira, A., Nomdedeu, B., Leoni, P., Clark, F.J., Radia, D., Rassam, S.M., Rogues, T., Ketterer, N., Brito-Babapulle, V, Dyer, M.J. and Catovsky, D. (2001) "High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H", Blood 98, 1721–1726.
   PubMed Web of Science ®Google Scholar
• Keating, M.J., O'Brien, S. and Albitar, M. (2002) "Emerging information on the use of rituximab in chronic lymphocytic leukemia", Semin. Oncol. 29, 70–74.
   PubMed Web of Science ®Google Scholar